Results for tag: "Brain Tumor Drug"

The Brain Tumor Drug market is a subset of the larger Brain Cancer Drug market. It is composed of drugs used to treat brain tumors, which are abnormal growths of cells in the brain. These drugs are used to reduce the size of the tumor, slow its growth, and reduce symptoms. They can be administered orally, intravenously, or intrathecally. Common drugs used to treat brain tumors include temozolomide, bevacizumab, and lomustine. The Brain Tumor Drug market is highly competitive, with many companies vying for market share. Some of the major players in the market include Novartis, Pfizer, Merck, and Roche. Other companies in the market include Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more